Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Top Cited Papers
Open Access
- 27 April 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 73 (11), 2065-2072
- https://doi.org/10.1093/cid/ciab381
Abstract
The SARS-CoV-2 pandemic has led to the development of various vaccines. Real-life data on immune responses elicited in the most vulnerable group of vaccinees over 80 years old is still underrepresented despite the prioritization of the elderly in vaccination campaigns. We conducted a cohort study with two age groups, young vaccinees below the age of 60 and elderly vaccinees over the age of 80, to compare their antibody responses to the first and second dose of the BNT162b2 COVID-19 vaccination. While the majority of participants in both groups produced specific IgG antibody titers against SARS-CoV-2 spike protein, titers were significantly lower in elderly participants. Although the increment of antibody levels after the second immunization was higher in elderly participants, the absolute mean titer of this group remained lower than the <60 group. After the second vaccination, 31.3 % of the elderly had no detectable neutralizing antibodies in contrast to the younger group, in which only 2.2% had no detectable neutralizing antibodies. Our data showed differences between the antibody responses raised after the first and second BNT162b2 vaccination, in particular lower frequencies of neutralizing antibodies in the elderly group. This suggests that this population needs to be closely monitored and may require earlier revaccination or/and an increased vaccine dose to ensure stronger long lasting immunity and protection against infection.Keywords
Funding Information
- Stiftung für Altersforschung, Düsseldorf
- Jürgen Manchot Foundation
- Deutsche Forschungsgemeinschaft
- German Research Foundation (GK1949/1)
- Forschungskommission of the Medical Faculty
- Heinrich-Heine-Universität Düsseldorf
This publication has 42 references indexed in Scilit:
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic InterventionFrontiers in Immunology, 2019
- Immunosenescence and human vaccine immune responsesImmunity & Ageing, 2019
- Immunosenescence: Implications for response to infection and vaccination in older peopleMaturitas, 2015
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older AdultsThe New England Journal of Medicine, 2014
- Developing mRNA-vaccine technologiesRNA Biology, 2012
- Hallmarks of human “immunosenescence”: adaptation or dysregulation?Immunity & Ageing, 2012
- Quantity, not quality, of antibody response decreased in the elderlyJCI Insight, 2011
- Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodiesJCI Insight, 2011
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010